|

Arthritis Clinical Trials in Texas

63 recruiting studies across 7 cities

Browse by City

Houston
42 trials
Arlington
35 trials
Dallas
35 trials
Fort Worth
35 trials
Austin
12 trials
San Antonio
10 trials
El Paso
4 trials

All Trials in Texas

Phase
Trial Phase Dist.
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)Phase 2<1 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.Phase 2<1 mi
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseasePhase 4<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 3<1 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPhase 3<1 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainPhase 2<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 3<1 mi
ConsideRAte Study - Splenic Stimulation for RAN/A<1 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.Phase 3<1 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPhase 2<1 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisPhase 2<1 mi
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic ArthritisPhase 3<1 mi
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisPhase 2<1 mi
Safety and Efficacy of ABP-745 in Participants With an Acute Gout FlarePhase 2<1 mi
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic ArthritisPhase 3<1 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabPhase 3<1 mi
Study of GS-0151 in Participants With Rheumatoid ArthritisPhase 1<1 mi
MOTION Clinical TrialN/A<1 mi
SMR Stemless Reverse Vs SMR Reverse Shoulder SystemN/A<1 mi
RA-PRO PRAGMATIC TRIALPhase 3<1 mi
Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsPhase 3<1 mi
Upper and Lower Extremity Exercise and Exercise-Induced Hypoalgesia in Knee OsteoarthritisN/A<1 mi
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).Phase 1<1 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Phase 4<1 mi
Study of GS-0272 in Participants With Rheumatoid ArthritisPhase 1<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 3<1 mi
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable CancerPhase 1<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneePhase 3<1 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)Phase 1<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesPhase 3<1 mi
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid ArthritisPhase 2<1 mi
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)—<1 mi
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic—<1 mi
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement SystemN/A<1 mi
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)Phase 2<1 mi
R-2487 in Patients With Rheumatoid ArthritisPhase 1<1 mi
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy—<1 mi
Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle ArthroplastyPhase 4<1 mi
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesPhase 2<1 mi
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors—<1 mi
The Myelin Disorders Biorepository Project—<1 mi
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic ArthritisPhase 3<1 mi
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the KneePhase 2<1 mi
Does Joint Lavage Reduce Intraarticular Inflammation in High-energy Tibial Pilon Fractures?N/A4 mi
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed PatientsPhase 24 mi
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease—7 mi
FX Shoulder Prospective Clinical Study—8 mi
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid ArthritisPhase 29 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic DrugPhase 310 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsPhase 110 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Phase 310 mi
Nipocalimab in Moderate to Severe Sjogren's DiseasePhase 318 mi
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's SyndromePhase 318 mi
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's DiseasePhase 118 mi
MDR - PMCF Study for Taperloc Complete Stems—18 mi
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic ArthritisPhase 324 mi
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE ParticipantsPhase 124 mi
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic ArthritisPhase 428 mi
A Study of SPY072 in Rheumatic DiseasePhase 228 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee OsteoarthritisEarly 144 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar PainPhase 144 mi
Primary Subtalar Arthrodesis for Calcaneal FracturesN/A47 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.